ABT peer analysis
Abbott (ABT) against its competitors: price, today's move, 1-year return and market value side by side.
ABT and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BDX Becton Dickinson | $198.19 | 0.16% | 10.49% | $53.90B |
| BSX Boston Scientific | $43.29 | 3.12% | -56.96% | $60.84B |
| DHR Danaher | $229.42 | -1.21% | 6.68% | $163.25B |
| EW Edwards Lifesciences | $94.29 | 2.48% | 12.95% | $53.03B |
| GEHC GE HealthCare | $79.95 | 4.41% | 6.60% | – |
| JNJ Johnson & Johnson | $269.26 | -1.44% | 42.43% | $657.68B |
| MDT Medtronic | $97.62 | 1.12% | 7.31% | $123.49B |
| SYK Stryker | $299.61 | 2.66% | -18.80% | $111.95B |
| TMO Thermo Fisher | $685.00 | -1.72% | 23.15% | $257.71B |
| ABT Abbott | $108.48 | 2.15% | -12.98% | $183.77B |
- ABT's peers: BDX (Becton Dickinson), BSX (Boston Scientific), DHR (Danaher), EW (Edwards Lifesciences), GEHC (GE HealthCare), JNJ (Johnson & Johnson), MDT (Medtronic), SYK (Stryker).
Updated 2026-11-02 17:54 UTC